This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -92.27M -46.28M 53.82M -38.46M
Operating Gains/Losses 9.55M 0.00 -16.27M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -4.86M -675.00K 29.00K -1.13M
(Increase) Decrease in Inventories -6.00M -1.15M 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 8.49M -1.10M -1.10M 5.21M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 138.00K 0.00
(Increase) Decrease In Other Working Capital 9.12M 229.00K 1.24M 64.00K
Other Non-Cash Items 15.32M 1.10M -77.04M 241.00K
Net Cash From Continuing Operations -57.95M -47.20M -38.21M -32.54M
Net Cash From Discontinued Operations 0.00 0.00 2.02M 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -57.95M -47.20M -36.18M -32.54M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 75.81M 49.47M 26.87M 58.90M
Purchases of Property, Plant & Equipment -2.35M -753.00K -685.00K -294.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -85.57M -97.67M -17.89M -32.78M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -12.11M -48.96M 33.90M 25.82M
Issuance of Debt 90.00M 0.00 30.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.44M 100.74M 29.00K 4.00K
Repayment of Long-Term Debt -26.07M -6.78M 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -3.63M -6.04M -975.00K -947.00K
Net Cash From Financing Activities 62.74M 87.92M 27.09M -943.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -7.32M -8.24M 24.80M -7.66M
SUPN News

SUPN Supernus Pharmaceuticals Inc

Analysts Ratings for SUPN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SUPN ANALYST REPORT

Brokerage Partners

SUPN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs